Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Reclassifying myelodysplastic syndromes: what's where in the new WHO and why.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reclassifying myelodysplastic syndromes: what's where in the new WHO and why.
Reclassifying myelodysplastic syndromes: what's where in the new WHO and why. Hematology Am Soc Hematol Educ Program. 2015; 2015:294-8.
View in:
PubMed
subject areas
Anemia, Sideroblastic
Cytogenetics
DNA Mutational Analysis
Flow Cytometry
Gene Deletion
Hematology
Humans
Immunophenotyping
Mutation
Myelodysplastic Syndromes
Phosphoproteins
Ribonucleoprotein, U2 Small Nuclear
RNA Splicing Factors
World Health Organization
authors with profiles
Daniel Arber